263 related articles for article (PubMed ID: 31151469)
21. Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis.
Tan D; Fu Y; Tong W; Li F
Int J Surg; 2018 Jul; 55():128-138. PubMed ID: 29807167
[TBL] [Abstract][Full Text] [Related]
22. Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Itabashi M; Ishibashi D; Yamamoto E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Hattori Y; Motohashi K; Takasaki H; Ohshima R; Hashimoto C; Yamazaki E; Fujimaki K; Sakai R; Fujisawa S; Motomura S; Ishigatsubo Y
Eur J Haematol; 2014 Mar; 92(3):204-10. PubMed ID: 24283206
[TBL] [Abstract][Full Text] [Related]
23. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.
Zhang Y; Liu Y; Qiu X; Yan B
Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263
[No Abstract] [Full Text] [Related]
24. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
[TBL] [Abstract][Full Text] [Related]
25. Prognostic role of the lymphocyte-to-monocyte ratio for clinical outcomes of patients with progressive radioiodine-refractory differentiated thyroid carcinoma treated by sorafenib.
Ahn J; Song E; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
Clin Endocrinol (Oxf); 2020 Jan; 92(1):71-76. PubMed ID: 31663136
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis.
Wang Y; Xu C; Zhang Z
BMC Med; 2023 Dec; 21(1):486. PubMed ID: 38053096
[TBL] [Abstract][Full Text] [Related]
27. The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Stotz M; Szkandera J; Stojakovic T; Seidel J; Samonigg H; Kornprat P; Schaberl-Moser R; Seggewies F; Hoefler G; Gerger A; Pichler M
Clin Chem Lab Med; 2015 Feb; 53(3):499-506. PubMed ID: 25389993
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of lymphocyte-to-monocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Mei P; Feng W; Zhan Y; Guo X
Front Immunol; 2023; 14():1321584. PubMed ID: 38090560
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.
Lim JU; Yeo CD; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
PLoS One; 2018; 13(7):e0200341. PubMed ID: 30005083
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study.
Lee SF; Luque-Fernandez MA
BMJ Open; 2017 Nov; 7(11):e017904. PubMed ID: 29101140
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer.
He J; Lv P; Yang X; Chen Y; Liu C; Qiu X
Tumour Biol; 2016 Jul; 37(7):9037-43. PubMed ID: 26762408
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis.
Mao Y; Chen D; Duan S; Zhao Y; Wu C; Zhu F; Chen C; Chen Y
Cancer Cell Int; 2018; 18():201. PubMed ID: 30534002
[TBL] [Abstract][Full Text] [Related]
33. Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis.
Hu RJ; Liu Q; Ma JY; Zhou J; Liu G
Clin Chim Acta; 2018 Sep; 484():1-6. PubMed ID: 29775617
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with urologic tumors: A PRISMA-compliant meta-analysis.
Li J; Cheng Y; Ji Z
Medicine (Baltimore); 2019 Jan; 98(2):e14091. PubMed ID: 30633220
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis.
Chen S; Zhang L; Yan G; Cheng S; Fathy AH; Yan N; Zhao Y
Biomed Res Int; 2017; 2017():7943467. PubMed ID: 28815182
[TBL] [Abstract][Full Text] [Related]
36. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
37. The absolute lymphocyte to monocyte ratio is associated with poor prognosis in classical Hodgkin lymphoma patients younger than 60 years of age.
Koh YW; Jung SJ; Yoon DH; Suh C; Cha HJ; Go H; Kim JE; Kim CW; Huh J
Hematol Oncol; 2015 Sep; 33(3):133-40. PubMed ID: 25224646
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Significance of Pretreatment Lymphocyte-to-Monocyte Ratio in Patients with Tongue Cancer.
Furukawa K; Kawasaki G; Naruse T; Umeda M
Anticancer Res; 2019 Jan; 39(1):405-412. PubMed ID: 30591487
[TBL] [Abstract][Full Text] [Related]
39. The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis.
Wang X; Su S; Guo Y
Oncotarget; 2017 Oct; 8(48):84506-84514. PubMed ID: 29137443
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]